Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo

On the origin of cancer cells

Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905

Comprehensive molecular characterization of clear cell renal cell carcinoma

The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485

Renal cell carcinoma

Hsieh, J. J., Purdue, M. P., Signoretti, S., Swanton, C., Albiges, L., Schmidinger, M., Heng, D. Y., Larkin, J., & Ficarra, V. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.9 · Cited by 2,426

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267

Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791

Glucose feeds the TCA cycle via circulating lactate

Hui, S., Ghergurovich, J. M., Morscher, R. J., Jang, C., Teng, X., Lu, W., Esparza, L. A., Reya, T., Zhan, L., Yanxiang Guo, J., et al. (2017) · Nature · doi:10.1038/nature24057 · Cited by 1,721

Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation

Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386

Lactate Metabolism in Human Lung Tumors

Faubert, B., Li, K. Y., Cai, L., Hensley, C. T., Kim, J., Zacharias, L. G., Yang, C., Do, Q. N., Doucette, S., Burguete, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.019 · Cited by 1,343

HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations

Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335

Identification of cuproptosis-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma

Ya, H., Zhang, H., Li, J., Zhou, H., Wang, F., Zhang, G., & Wen, Y. (2024) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2023.100338 · Cited by 3

Metabolic pathway analysis of tumors using stable isotopes

Bi, Q., Zhao, J., Nie, J. H., & Huang, F. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.05.002 · Cited by 3

Metabolic Reprogramming and Molecular Rewiring in Cancer: Therapeutic Opportunities

Meiliana, A., Dewi, N. M., & Wijaya, A. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i2.1598 · Cited by 3

ZNF668: a new diagnostic predictor of kidney renal clear cell carcinoma

Wei, C., Gao, Y., Chen, X., Zhao, C., & Li, P. (2021) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001149 · Cited by 3

Bonded cumomer analysis of tumor metabolism based on 13C magnetic resonance spectroscopy

Shestov, A. A., Nath, K., NELSON, D. S., Wasik, M. A., & Glickson, J. D. (2022) · NMR in Biomedicine · doi:10.1002/nbm.4716 · Cited by 3

A novel NSUN5/ENO3 pathway promotes the Warburg effect and cell growth in clear cell renal cell carcinoma by 5-methylcytosine-stabilized ENO3 mRNA.

Wang, J., Ju, H.-J., Zhang, F., Tian, H., Wang, W., Yulin, M., Xu, W., & Wang, Y. (2023) · PubMed Central · Cited by 3

Influence of Dietary Polyunsaturated Fatty Acid Intake on Potential Lipid Metabolite Diagnostic Markers in Renal Cell Carcinoma: A Case-Control Study

Kim, Y.-H., Chung, J., Lee, H. H., Park, J., & Kim, M. K. (2024) · Nutrients · doi:10.3390/nu16091265 · Cited by 3

Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo

Bosc, C., & Chandel, N. S. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061424-125611 · Cited by 3

Solute carrier family 6 member 3 promotes the development of clear cell renal cell carcinoma by enhancing glycolysis and inhibiting ferroptosis

Zhao, H., Ji, Y., & Liang, C. (2025) · CytoJournal · doi:10.25259/cytojournal_35_2025 · Cited by 3

Recent progress in analysis of intermediary metabolism by ex vivo 13C NMR

Malloy, C. R., Sherry, A. D., Alger, J. R., & Jin, E. S. (2022) · NMR in Biomedicine · doi:10.1002/nbm.4817 · Cited by 3

Mitochondrial transporter expression patterns distinguish tumor from normal tissue and identify cancer subtypes with different survival and metabolism

Wohlrab, H., Signoretti, S., Rameh, L. E., DeConti, D. K., & Hansen, S. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-21411-0 · Cited by 4

Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma

Tan, D., Miao, D., Zhao, C., Shi, J., Lv, Q., Xiong, Z., Yang, H., & Zhang, X. (2023) · BMC Cancer · doi:10.1186/s12885-023-10740-6 · Cited by 3

Comparison of the Fatty Acid Metabolism Pathway in Pan-Renal Cell Carcinoma: Evidence from Bioinformatics

Wu, P., Xu, Y., Li, J., Li, X., Zhang, P., Ruan, N., Zhang, C., Sun, P., Wang, Q., & Wu, G. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/8842105 · Cited by 3

TGF-β signaling suppresses TCA cycle metabolism in renal cancerPreprint

Nam, H., Kundu, A., Karki, S., Brinkley, G. J., Chandrashekar, D. S., Kirkman, R. L., Liu, J., Liberti, M. V., Locasale, J. W., Mitchell, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.19.429599 · Cited by 3

Metabolic landscape of clear cell renal cell carcinoma and search for metabolites predictive of drug response

Ozawa, M., Naito, S., Makinoshima, H., Ito, H., Tsuya, A., Narisawa, T., Fukuhara, H., Takai, Y., Ushijima, M., Yagi, M., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14661-4 · Cited by 2

Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinoma

Yong, C., Schmidt, C., Yang, M. H., von Kriegsheim, A., Warren, A. Y., Anand, S., Armitage, J. N., Riddick, A. C. P., Mitchell, T. J., Patil, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65676-1 · Cited by 2

Targeted metabolism creates possibilities for lung cancer treatment in the precision tumor era

Huang, X., Shen, H., Shao, C., Wang, L., Zheng, X., Wang, Y., Qiu, L., Zhang, S., Zhang, T., & Lu, Z. (2026) · Respiratory Research · doi:10.1186/s12931-025-03383-7 · Cited by 2

First-in-class HIF-2α therapy in genitourinary oncology: Belzutifan from von Hippel–Lindau disease to advanced renal cell carcinoma

Karaman, İ., Erdem, D., & Çetin, B. (2026) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-025-04861-x · Cited by 2

Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study

Rolley, C., Zidane-Marinnes, M., Nedelcu, C., Barth, M., Saulnier, P., Procaccio, V., & Bigot, P. (2026) · Nutrients · doi:10.3390/nu18111712 · Cited by 2

Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer

Ogbonna, H. N., & Norian, L. A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1866875 · Cited by 2

Targeted Quantification of Carbon Metabolites Identifies Metabolic Progression Markers and an Undiagnosed Case of SDH-Deficient Clear Cell Renal Cell Carcinoma in a German Cohort

William, D., Erdmann, K., Ottemöller, J., Mangelis, A., Conrad, C., Peitzsch, M., Schröck, E., Eisenhofer, G., Zacharis, A., Fuessel, S., et al. (2021) · Metabolites · doi:10.3390/metabo11110764 · Cited by 2

Histo-molecular differentiation of renal cancer subtypes by mass spectrometry imaging and rapid proteome profiling of formalin-fixed paraffin-embedded tumor tissue sectionsPreprint

Möginger, U., Marcussen, N., & Jensen, O. N. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.19.956433 · Cited by 2

Mass spectrometry and machine learning for classification and molecular phenotyping of renal cell carcinoma and benign tumorsPreprint

Thomsen, A. A., Rabjerg, M., Marcussen, N., Lund, L. C., & Jensen, O. N. (2026) · medRxiv · doi:10.64898/2026.01.13.26343935 · Cited by 2

Lipid droplets: a candidate new research field for epithelial ovarian cancer

Koizume, S., Takahashi, T., & Miyagi, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1437161 · Cited by 1

Clear cell renal cell carcinoma and metabolic reprogramming: New therapeutic targets for kidney cancer treatment

Dou, Y. (2025) · New cell · doi:10.61958/ncjt1177 · Cited by 1

Mitochondrial changes in clear cell renal cell carcinoma: mechanisms and potential targets

Yang, J., Pan, X., Luo, X., Zheng, X., & Wang, J. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153354 · Cited by 1

PNKD Mediates Lactate‐Driven Tumor Progression in Clear Cell Renal Cell Carcinoma

Zhang, X., Guo, W., Yu, M., Wang, Y., Cui, B., Zhang, Y., Yan, J., & Wang, K. (2026) · Human Mutation · doi:10.1155/humu/8430177 · Cited by 1

Emerging roles for the epigenetic modifiers PBRM1 SETD2 and BAP1 in clear cell renal cell carcinoma pathogenesis and prognosis beyond VHL

Jixiang, B., Chen, X., Xiaoxuan, P., Mingli, S., Jieru, H., & Shuhui, W. (2026) · Discover Oncology · doi:10.1007/s12672-026-04707-9 · Cited by 2

SPDEF promotes clear cell renal cell carcinoma progression by transcriptionally activating ELOVL2-mediated lipid metabolic reprogramming

Zhang, P., Yu, W., Luo, H., Wang, D., Li, M., Wang, T., Guo, Y., Xiong, W., Gong, B., & Yu, H. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168315 · Cited by 1

Flux measurements of the tricarboxylic acid cycle in the tumors of mice

Liu, S., & Locasale, J. W. (2023) · Life Metabolism · doi:10.1093/lifemeta/load020 · Cited by 1

Live Metabolomics with NMR

Jin, A. Y., de Guzman, A. C. V., Lee, S., Cha, J. W., & Park, S. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c04505 · Cited by 1

FUT8 reprograms glycolytic metabolism to promote PKM2 lactylation and drive clear cell renal cell carcinoma progression

Guo, Z., Jiang, H., Wang, X., Xuan, K., Zhong, H., Liu, C., Zhang, M., Li, Z., Huang, W., & Sun, Y. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03013-1 · Cited by 1

VGF-Mediated Mitochondrial Remodeling Fuels Lung Adenocarcinoma Brain Metastasis

Wang, Y., Sheng, X., Yang, Y., Liu, C., Wang, S., Guo, R., Gu, Y., Chen, M. M., Zhang, H., Du, J., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-2712 · Cited by 1

Why CAR T cell therapy fails in renal cell carcinoma

Hua-jun, Z., Han, L.-Z., Zhang, X., & Ge, Y.-L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1828738 · Cited by 1

Construction and Validation of an Oxidative Phosphorylation Signature in High‐Grade Glioma and Potential Inhibitors Screening

Lu, H., Zhao, W., Zhang, B., Xie, Y., He, J., Yang, H., & Wang, Z. (2024) · Analytical Cellular Pathology · doi:10.1155/2024/2868534 · Cited by 1

Potential of Metabolic MRI to Address Unmet Clinical Needs in Localised Kidney Cancer

Horvat‐Menih, I., Stewart, G. D., & Gallagher, F. A. (2025) · Cancers · doi:10.3390/cancers17111773 · Cited by 1

Sweet success for ccRCC isotope tracing

Barranco, C. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0061-z

Tracking Metabolic Rewiring of Cancer Metabolism in Humans Using Isotope-Resolved NMR

Pichumani, K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9690-2_10

906 Immunogenomic evaluation of clear cell renal carcinoma uncovers HK3 as a myeloid specific metabolic enzyme

Reinfeld, B. I., Madden, M. Z., Wolf, M. M., de Cubas, A., Haake, S. M., Hongo, R. A., Axelrod, M. L., Bader, J. E., Obradović, A., Greenwood, D. L., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-sitc2021.906

The time has come to pull renal cancer’s sweet tooth

Kinnaird, A. S., & Michelakis, E. D. (2019) · Translational Cancer Research · doi:10.21037/tcr.2018.12.31

Papel do microRNA-33A e da proteína sirtuina 6 no metabolismo e progressão do câncer de cólon em camundongos submetidos ao treinamento físico aeróbico

Gomes, J. L. P. (2022) · doi:10.11606/t.39.2022.tde-16052022-111850

Introduction on Cancerous Cells and Metastasis

Mohammadi‐Motlagh, H., Sadeghalvad, M., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_37-1

Author response: Mitochondrial redox adaptations enable alternative aspartate synthesis in SDH-deficient cells

Hart, M. L., Quon, E., Vigil, A.-L. B. G., Engstrom, I. A., Newsom, O. J., Davidsen, K., Hoellerbauer, P., Carlisle, S. M., & Sullivan, L. B. (2023) · eLife · doi:10.7554/elife.78654.sa2

Supplementary Data and Methods from Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis

Broadfield, L. A., Duarte, J. A. G., Schmieder, R., Broekaert, D., Veys, K., Planque, M., Vriens, K., Karasawa, Y., Napolitano, F., Fujita, S., et al. (2023) · doi:10.1158/0008-5472.22430289

Flux estimation analysis systematically characterizes the metabolic shifts of the central metabolism pathway in human cancer

Yang, G. M., Huang, S., Hu, K., Lu, A. Z., Yang, J., Meroueh, N., Dang, P., Wang, Y., Zhu, H., Cao, S., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1117810

Identification of a Combined Immune- and Metabolism- Related Prognostic Signature for Clear Cell Renal Cell CarcinomaPreprint

Xia, Z., Dong, Y., Xu, S., Liu, B., Liao, J., Guo, W., Wang, S., Cui, Z., Wang, X., Zheng, Y., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3095861/v1

Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availabilityPreprint

Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652.1

eLife Assessment: Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability

Zhang, Q. (2024) · eLife · doi:10.7554/elife.95652.1.sa3

Additional file 2 of PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance

Feng, C., Li, Y., Li, K., Lyu, Y., Zhu, W., Jiang, H., & Wen, H. (2021) · Figshare · doi:10.6084/m9.figshare.16714134

Additional file 4 of PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance

Feng, C., Li, Y., Li, K., Lyu, Y., Zhu, W., Jiang, H., & Wen, H. (2021) · Figshare · doi:10.6084/m9.figshare.16714140

Additional file 1 of PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance

Feng, C., Li, Y., Li, K., Lyu, Y., Zhu, W., Jiang, H., & Wen, H. (2021) · Figshare · doi:10.6084/m9.figshare.16714131

Additional file 3 of PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance

Feng, C., Li, Y., Li, K., Lyu, Y., Zhu, W., Jiang, H., & Wen, H. (2021) · Figshare · doi:10.6084/m9.figshare.16714137

Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availabilityPreprint

Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652.2

Reviewer #1 (Public Review): Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability

(2024) · eLife · doi:10.7554/elife.95652.2.sa2

Metabolic Reprogramming of Clear Cell Renal Cell Carcinoma and Its Clinical Significance

周, 文. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451486

Reviewer #2 (Public review): Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability

(2024) · eLife · doi:10.7554/elife.95652.3.sa2

Investigating the role of mitochondrial energy rewiring throughout prostate cancer progression

Bidgood, C. L. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.248849

Machine learning-based analysis identifies glucose metabolism-related genes ADPGK as potential diagnostic biomarkers for clear cell renal cell carcinoma

Li, T., Wang, S., Li, G., Qi, X., Wu, G., & Che, X. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1559887

Introduction on Cancerous Cells and Metastasis

Mohammadi‐Motlagh, H., Sadeghalvad, M., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_37

VHL Gene Restoration Supports RCC Reprogramming to iPSCs but Does Not Ensure Line Stability

Lichner, Z., Shamshirgaran, Y., Pieczonka, K., Jonebring, A., Kibschull, M., Shynlova, O. P., Meens, J., Kim, R. H., Ailles, L., Bilican, B., et al. (2025) · Cancers · doi:10.3390/cancers17223693

LAC-TME classifier: machine learning-driven model predicts survival and prioritizes targeted therapy in clear cell renal cell carcinoma

He, J., Qi, L., Cai, Y., Chen, M., & Wang, Y. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06365-w

Additional file 3 of Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma

Tan, D., Miao, D., Zhao, C., Shi, J., Lv, Q., Xiong, Z., Yang, H., & Zhang, X. (2023) · Figshare · doi:10.6084/m9.figshare.22620215

Additional file 5 of Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma

Tan, D., Miao, D., Zhao, C., Shi, J., Lv, Q., Xiong, Z., Yang, H., & Zhang, X. (2023) · Figshare · doi:10.6084/m9.figshare.22620221

Additional file 2 of Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma

Tan, D., Miao, D., Zhao, C., Shi, J., Lv, Q., Xiong, Z., Yang, H., & Zhang, X. (2023) · Figshare · doi:10.6084/m9.figshare.22620212

Additional file 4 of Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma

Tan, D., Miao, D., Zhao, C., Shi, J., Lv, Q., Xiong, Z., Yang, H., & Zhang, X. (2023) · Figshare · doi:10.6084/m9.figshare.22620218

Additional file 1 of Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma

Tan, D., Miao, D., Zhao, C., Shi, J., Lv, Q., Xiong, Z., Yang, H., & Zhang, X. (2023) · Figshare · doi:10.6084/m9.figshare.22620209

Additional file 1 of In vivo assessment of glutamine anaplerosis into the TCA cycle in human pre-malignant and malignant clonal plasma cells

Gonsalves, W. I., Jang, J. S., Jessen, E., Hitosugi, T., Evans, L. A., Jevremović, D., Pettersson, X.-M., Bush, A. G., Gransee, J., Anderson, E. I., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13467787

Hereditary cancer syndromes linked to oxidative phosphorylation insufficiency

Kaplan, B., Duraj, T., Lee, D. C., & Seyfried, T. N. (2025) · ONCOLOGIE · doi:10.1515/oncologie-2025-0301

Decoding the metabolic-immune axis for novel therapeutics in bladder cancer

Zhou, M., Xue, X., Li, H., Chen, Z., Nie, Q., & Lai, Y. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189569

AATF supports proliferation of glioblastoma cells by sustaining mitochondrial respiration through an NRF-1-dependent mechanism

Sorino, C., Giovenale, S. D., Falcone, I., Auciello, F. R., Pulito, C., Sardo, F. L., Scalera, S., Nicola, F. D., Catena, V., Ciuffreda, L., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08617-0

Stable Isotopes for the Study of Energy Nutrient Metabolic Pathways in Relation to Health and Disease

Azzout‐Marniche, D., & Tomé, D. (2026) · Metabolites · doi:10.3390/metabo16040231

Régime cétogène et cancer du rein

Rolley, C. (2021) · theses.fr (ABES) · doi:10.70675/4f4b1053z14f7z419aza2b9z2a5c99538bde

Metformin treatment impairs the adenine nucleotide translocator activity and energy metabolism in human clear cell renal carcinoma cells

Lidia de, B. A. R. I., Caratozzolo, M. F., Petrosillo, G., Calò, M., Antognelli, C., Armeni, T., Scirè, A., & Kalapos, M. P. (2026) · Scientific Reports · doi:10.1038/s41598-026-48200-3

An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN-Mediated Immune Evasion as a Therapeutic Vulnerability: Evidence from In Vitro and In Vivo Studies

Xia, Z., Dong, Y., Zhang, X., Xia, W., Wang, H., Zhou, Y., Qi, Y., Liang, Y., Li, Z., Zhang, Y., et al. (2026) · Cancers · doi:10.3390/cancers18091373

Sodium p-perfluorous nonenoxybenzenesulfonate directly targets on mitochondrial proteins to disrupt metabolic cascade and promote nephrotoxicity

Lyu, Y., Guo, R., Gui, B., Zhong, W., & Zhu, L. Y. (2026) · Environment International · doi:10.1016/j.envint.2026.110308

Driver-Independent Suppression of Nuclear-Encoded Mitochondrial Metabolism at Stage I in Clear Cell Renal Cell Carcinoma: A Multi-Cohort Transcriptomic AnalysisPreprint

Gomosani, A. A., Marghalani, H., & Matar, L. A. (2026) · Research Square · doi:10.21203/rs.3.rs-9772400/v1

Transcription Factor ATF4 Deletion Reprograms Glucose Metabolism in Clear Cell Renal Cell Carcinoma

Chi, Y., Chen, Q., Aguila, E. M. D., Gross, S. S., Wagner, J. A., Reilly, S. M., Nanus, D. M., & Gudas, L. J. (2026) · Cancers · doi:10.3390/cancers18121953

Overexpression of FTO ameliorates chronic glomerulonephritis by inhibiting glycolysis in glomerular mesangial cells associated with ADPGK m6A modification

Zhao, S., Zheng, W., Guo, M., Jiarong, G., & Zhuang, X. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05683-1

Targeting enolase isoenzyme 2 enables precision glycolysis inhibition in VHL-mutant renal cell carcinoma

Yao, J., Fan, X., Xin, H., Wan, F., Dong, X., Sun, Q., Huang, X., Liu, H., Chen, X., Jia, Y., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09102-4

Stable Isotope‐Resolved Metabolomics in Elucidating Mitochondrial Metabolic Reprogramming and Therapeutic Targets

Yang, D., Wu, X., Luo, X., Teng, Y., Duan, X., Kang, T., & Wu, W. (2026) · Biomedical Chromatography · doi:10.1002/bmc.70560

Disentangling the Crabtree and Warburg effects across syngeneic non-tumor and tumor cellsPreprint

Duraj, T., Miller, E. Y., Ta, N. L., Lee, C., Lee, D. C., Ramos, M. B., Aristizabal‐Henao, J. J., Kiebish, M., Mukherjee, P., Pellicer, M. B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.06.756891

Hypoxia Signatures in Renal Cell Carcinoma: From HIF-Mediated Omics Remodeling to Precision Diagnostics

Mahalinga, M., Rai, A. B., & Prasad, T. S. K. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6c00675

A roadmap for quantifying metabolism in patients with cancer

Meghdadi, B., Wahl, D. R., & Nagrath, D. (2026) · Trends in cancer · doi:10.1016/j.trecan.2026.10.005

The Warburg effect in hominis: isotope-resolved metabolism in ccRCC

Crooks, D. R., & Linehan, W. M. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0110-1 · Cited by 6

Watching kidney cancer metabolism

Yang, M. (2018) · Science · doi:10.1126/science.361.6406.988-c

Sweet success for ccRCC isotope tracing

Barranco, C. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0061-z

Abstract IA017: Metabolic reprogramming and kidney cancer progression

DeBerardinis, R. J. (2023) · Cancer Research · doi:10.1158/1538-7445.kidney23-ia017

Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate

Nilsson, H., Lindgren, D., Forsberg, A. M., Mulder, H., Axelson, H., & Johansson, M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.545 · Cited by 77